Thank goodness Baltia has so many things going for them.

New Post Public Reply Private Reply Replies (0) Message Board
Mogul40
Thank goodness Baltia has so many things going for them. Can you imagine being these morons. From cranky flier.com

Avatar’s model hasn’t changed, and it goes against pretty much everything going on in the industry today. The airline wants to pick up some old 747-400s, fill them up with fares “50% or lower than current carriers,” and fly them back and forth across the country making a couple stops each way.

Sounds great, right? But, wait. It gets better. There will be no bag fees for the first two checked bags. Oh, and wifi will be free. If you’re wondering how this airline could possibly make any money, you’re not alone.

The basic premise is hugely flawed. The airline is going to work its airplanes hard, flying them a ton. Each 747 will have 539 coach seats and 42 “Office” class seats. The general plan is to work unit costs down as low as possible by spreading them out over a ton of people all day long. But there’s a huge problem here.

The airline’s first route will be a milk run: LA to Vegas to New York to Miami and back. One airplane will start the morning in LA and head east while the other starts in Miami and heads west. They’ll get to the other side and then turn around. This is a hilariously bad plan.

How many of those 581 seats do you think will be filled going from LA to Vegas early in the morning on a Wednesday? Not a lot. You can do the same thing throughout the network and find plenty of holes. Airlines that focus on low costs thrive on scarcity. Allegiant flies to small cities and creates demand with low fares. But it has only around 150 seats to fill and it flies only a few times a week on many routes. If the demand isn’t there during certain days of the week or different seasons, it just sits an airplane.

Avatar won’t have that. It will have far too many seats and will bleed out all too quickly unless it can start charging a lot more for those seats. So far its grand plan is to do all kinds of promotional stuff with advertisers to generate revenue. It’s just not going to happen for a small airline that nobody cares about.

Maybe travel agents can help generate demand? Nope. Avatar is actually going to charge travel agents for the right to book on the airline. But what that gets is the ability to reserve seats and not provide a name until 48 hours prior to departure. What the heck…

The route map only starts to look goofier as the airline grows. Take a look at the Indiegogo presentation. The airline will just keep running more airplanes on similar routes (Orlando instead of Miami, for instance). By year two, they run out of ideas. They want to fly a 747 from Vegas to Albuquerque and on to Orlando. This is amazing.

And how are the people of Avatar going to make all this happen? Well they aren’t, because they’ve been trying to do the same thing for years and nobody buys this plan. But now they’re hoping to tap into the kindness of the ignorant public. Do you want to help Avatar reach its $5 million goal?

At last check, there were 2 donors who had chipped in $5 each. The airline is almost there. It says it wants the money to market its $300 million equity offering. Though I find myself wondering if they’ll end up having to use the money to pay DOT fines instead.

Avatar isn’t an airline at this point, but it’s offering perks to people who pay, and that sounds like they’re selling a product. That’s not allowed. For example, if you donate $3,000 you become a Founders Club member. That includes access to early boarding, lounges, and upgrades when the airline is flying. Does that sound similar to when California Pacific People Express got in trouble for selling frequent flier program membership before it started flying? Sounds like Avatar is walking quite the fine line here.

Baltia Air Lines Inc (BLTA) Stock Research Links

BLTA Board Company Profile Buy Rating Time & Sales News Filings Financials
#LiFEChangingUSGlobal
#FlyingsoonWithTonyandUSGL
#kickthetrashbacktoscumhub
#NOVOICEFORLOSERS
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading